Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for AIDS-associated cancers, as well as information about trials offered through the AIDS Malignancy Consortium (AMC). Trials are listed according to the type of tumor. To learn more about a study, choose from the list below.

Clicking a link below will scroll the
page down to the relevant section

AIDS-Associated Kaposi's Sarcoma
AIDS-Associated Lymphomas
AIDS Malignancy Consortium (AMC)'s Trials

AIDS-Associated Kaposi's Sarcoma

A Phase I/II Trial of PTC299 in Patients with HIV-Related Kaposi's Sarcoma
Krown, Susan, MD

[Protocol 08-064]

Top

AIDS-Associated Lymphomas

A Phase II Trial of Doxorubicin, Rituximab, Cyclophosphamide, Vincristine, and Prednisone (DR-COP) in Patients with Newly Diagnosed AIDS-Associated B-Cell Non-Hodgkin's Lymphoma
Noy, Ariela, MD

[Protocol 07-084]
Prospective Phase II Study of R-CODOX-M/IVAC, including Central Nervous System Penetration and Intensive Intrathecal Prophylaxis, in HIV-associated Burkitt's and Atypical Burkitt's Lymphoma
Noy, Ariela, MD

[Protocol 07-033]

Top

AIDS Malignancy Consortium (AMC)'s Trials

The AIDS Malignancy Consortium (AMC) is a National Cancer Institute-supported clinical trials group founded in 1995 to support innovative trials for AIDS-associated malignancies. The AMC is committed to enhancing therapeutic options for patients with AIDS-associated malignancies.

To see a list of current AMC clinical trials, visit their Web site.

Top

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org